You are here

Daiichi Sankyo

Daiichi Sankyo comes up way short of promised avian flu vaccine production

Fierce Pharma

Wed, 05/22/19 - 08:34 pm

Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No

BioSpace

Wed, 05/15/19 - 11:42 am

acute myeloid leukemia

FDA questions credibility of Daiichi data ahead of AdComm

Fierce Biotech

Mon, 05/13/19 - 09:32 am

acute myeloid leukemia

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Yahoo/Benzinga

Sat, 05/11/19 - 12:31 pm

The Medicines Company

AstraZeneca's share dilution gamble on Daiichi drug pays off

Biopharma Dive

Thu, 05/9/19 - 10:49 am

trastuzumab deruxtecan

metastatic breast cancer

AZ and Daiichi to file new breast cancer drug after trial success

Pharmaforum

Wed, 05/8/19 - 10:05 am

trastuzumab deruxtecan

antibody-drug conjugate

Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks

Fierce Biotech

Thu, 04/25/19 - 11:45 am

immuno-oncology

bispecific antibodies

AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal

Yahoo/Reuters

Fri, 03/29/19 - 10:06 am

trastuzumab deruxtecan

Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit

Fierce Biotech

Fri, 02/22/19 - 11:46 am

Daiichi gets speedy FDA review for rare cancer drug

Pharmaforum

Fri, 02/8/19 - 09:38 am

priority review

Daiichi Sankyo takes option on diabetes stem cell start-up

Pharmaforum

Sat, 01/12/19 - 11:30 am

Tokyo Institute of Technology

type 1 diabetes

OiDE BetaRevive

Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market

Endpoints

Fri, 01/4/19 - 09:20 am

Esperion Therapeutics

Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer

Pharmaceutical Business Review

Fri, 10/26/18 - 09:52 am

clinical trials

Daiichi Sankyo launches phase 1 trial of DS-1205 in EGFR-mutated NSCLC

Pharmaceutical Business Review

Fri, 10/19/18 - 10:53 pm

non-small cell lung cancer

Encouraging trial results for Daiichi anti-stroke therapy

The Pharma Letter

Fri, 05/18/18 - 09:41 pm

clinical trials

atrial fibrilation

Daiichi Sankyo in pursuit of Novartis’ Rydapt with next-generation FLT3 drug

Fierce Biotech

Wed, 05/9/18 - 09:21 am

acute myeloid leukemia

Daiichi Sankyo concedes an early setback on Duchenne MD drug, but doubles down on development

Endpoints

Wed, 04/25/18 - 09:50 am

Duchenne Muscular Dystrophy

Could This be the End of Flu Shots?

CP Wire

Fri, 04/20/18 - 09:18 am

influenza vaccines

Could This be the End of Flu Shots? - Updated

Fri, 04/20/18 - 11:52 am

influenza vaccines

Top 5 boards for week ending March 10, 2018

CP Wire

Sun, 03/11/18 - 03:05 pm

Pages